C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions

Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
11/2004
11/11/2004	US20040224377 Compositions and methods to quench light from optical reactions
11/11/2004	US20040224370 Fluorescence guided cell capture
11/11/2004	US20040224369 Identifying and ranking samples that form the most stable complexes with a target; characterization of relative binding strength
11/11/2004	US20040224363 Immunoglobulin for use in diagnosis and prognosis of metastatic breast cancer and degenerative neural conditions; drug screening; immunotherapy and diagnostics; anticarcinogenic agents
11/11/2004	US20040224360 Methods for diagnosing renal disorders
11/11/2004	US20040224359 Using matrix assisted laser desorption ionization/mass spectrometry to detect viral capsid particles in solution; screening for salmonella or escherichia
11/11/2004	US20040224356 Novel human enzymes of the metalloprotease family
11/11/2004	US20040224355 Using guanylate cyclase gene expression for imaging and treating primary and/or metastatic stomach or esophageal cancer; tissue targeted therapy; genetic vaccines; immunotherapy
11/11/2004	US20040224354 Capillary comprising inlet and outlet, a plurality of particles inside and probes immobilized on particles; for use in forming biochip microarrays for genomic analysis and disease diagnosis
11/11/2004	US20040224353 Nucleic acid detection methods using universal priming
11/11/2004	US20040224352 Identifying single nucleotide polymorphisms in amplicons using probes which recognize and bind upstream and downstream primimg sites; genomic and genotyping
11/11/2004	US20040224349 Methods of screening novel agents for use in cancer therapy and prevention
11/11/2004	US20040224348 Two oligonucleotides for use in in vitro diagnostic detection of pathogenic bacteria; identifying microorganisms associated with opportunistic infections in immunocompromised individuals
11/11/2004	US20040224347 Methods for identification, diagnosis, and treatment of breast cancer
11/11/2004	US20040224345 Using linked suite of programs for modeling parallel DNA synthesis using a polymerase enzyme; bioinformatics
11/11/2004	US20040224344 Methods and compositions to extract DNA, RNA and protein simultaneously from biological samples
11/11/2004	US20040224343 Increasing probabilty of biomolecule associations via exposing/incubating molecules with organic chemicals or bipolar reagents such as ethanol and methanol; intensifying biopolymers stability and reactability
11/11/2004	US20040224342 Method of detecting micrometastasis
11/11/2004	US20040224337 Use of biomolecular targets in the treatment and visualization of tumors
11/11/2004	US20040224336 RecA-assisted specific oligonucleotide extension method for detecting mutations, SNPs and specific sequences
11/11/2004	US20040224335 Methods and compositions for treatment of tumors using nucleic acid ligands to platelet-derived growth factor
11/11/2004	US20040224334 Computer system for use in designing and predicting probes complimentary to preferential gene sequences; bioinformatics and sequence determmination; genomics
11/11/2004	US20040224332 System and method for calibration and focusing a scanner instrument using elements associated with a biological probe array
11/11/2004	US20040224331 Generating genomic profile of cells based on restriction fragment length polymorphisms and heterologous primer; animal husbandry and plant breeding; high throughput assay
11/11/2004	US20040224330 Nucleic acid indexing
11/11/2004	US20040224326 Using non-photolithographic, non-spotting process for generating chip-like hybrid devices for use in genomic analysis
11/11/2004	US20040224325 Apparatus for detecting and replicating low copy nucleic acids for use in medicine, forensic science, crop and animal breeding; cancer diagnostics and pathogen detection; high throughput assay
11/11/2004	US20040224324 Happiar mapping
11/11/2004	US20040224323 PAK5 screening methods
11/11/2004	US20040224321 Micro/nano-structures fabricated by laser ablation for micro-array applications
11/11/2004	US20040224320 Method for efficiently determining a DNA strand break
11/11/2004	US20040224319 Analyte detection
11/11/2004	US20040224314 G-protein coupled receptors
11/11/2004	US20040224313 Comprises nucleotide sequences coding cytochrome p450 oxygenase variant for identifying modulator use in diagnosis, prognosis, treatment and prevention of cell proliferative disorders; antitumor agents
11/11/2004	US20040224312 Gene causative of rothmund-thomson syndrome and gene product
11/11/2004	US20040224311 Identifying nucleotide sequences mutation which generate viricide/protease/enzyme inhibitor resistant viral particles; genetic vaccines; enzyme inhibitors; viricides
11/11/2004	US20040224309 Nucleotide sequences coding viral genome for use in developing vaccine to prevent respiratory system infections; genetic vaccines
11/11/2004	US20040224307 Identifying polymorphism associated with lymphadenopathy associated viral resistance to enzyme inhibitors; prognosticating therapeutic effectiveness of vircidal agents on viral variants
11/11/2004	US20040224306 Monitoring therapeutic efficacy of chlorite mixture comprising three proinflammatory cytokine on treatment of viral, gastrointestinal, cardiovascular, inflammatory and autoimmue diseases
11/11/2004	US20040224137 coating electrode surfaces with amphipathic proteins, then contacting with electroactive proteins, enzymes, antibodies or receptors, to form biosensors; measuring potentials in solutions
11/11/2004	US20040223978 determining calciotropic activity of a preparation of Padina pavonica by culturing osteoblasts in a medium rich in calcium ions; adding the algae after complete development; eliminating calcium ions; acidifying to destroy extracellular matrix; filtering; determining concentration of fixed calcium ions
11/11/2004	US20040223964 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/11/2004	US20040223323 Optical information carrier comprising immobilized proteorhodopsin
11/11/2004	US20040222092 Electrochemical-sensor design
11/11/2004	DE10318115A1 Potentiometrische Sensoreinrichtung Potentiometric sensor device
11/11/2004	CA2528143A1 Method of diagnosing a genetic susceptibility for bone damage
11/11/2004	CA2524360A1 Novel composition and methods for the treatment of immune disorders
11/11/2004	CA2524248A1 Angiotensin ii receptor blockers for preventing the development or progression of microvascular disease due to diabetes
11/11/2004	CA2524173A1 Methods for diagnosing aml and mds differential gene expression
11/11/2004	CA2524064A1 Method for detection and characterization of pre-malignant transformation
11/11/2004	CA2523976A1 Computational methods and systems for multidimensional analysis
11/11/2004	CA2523975A1 Computational method and system for mass spectral analysis
11/11/2004	CA2523919A1 Method for nucleic acid sequencing
11/11/2004	CA2523912A1 Human antihuman interleukin-18 antibody, fragment thereof and method of using the same
11/11/2004	CA2523798A1 Methods for prognosis and treatment of solid tumors
11/11/2004	CA2523751A1 Array having substances fixed on support arranged with chromosomal order or sequence position information added thereto, process for producing the same, analytical system using the array and use of these
11/11/2004	CA2523645A1 Optical detector for enzyme activation
11/11/2004	CA2523600A1 Methods utilising g-protein coupled receptor 54
11/11/2004	CA2523578A1 Tissue protective cytokine receptor complex, assays for identifying tissue protective compounds and uses thereof
11/11/2004	CA2523537A1 Pathophysiology associated with a single gene (mass1) mutation underlying the robust audiogenic seizure phenotype in frings mice
11/11/2004	CA2523517A1 Bcl2l12 polypeptide activators and inhibitors
11/11/2004	CA2523501A1 Preservation of rna in a biological sample
11/11/2004	CA2523490A1 Fragmentation-based methods and systems for de novo sequencing
11/11/2004	CA2523442A1 Molecular detection systems utilizing reiterative oligonucleotide synthesis
11/11/2004	CA2523363A1 Compositions, targets, methods and devices for the therapy of ocular and periocular disorders
11/11/2004	CA2523319A1 Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences and methods for propagating virus
11/11/2004	CA2523016A1 Detection of herpes simplex virus types 1 and 2 by nucleic acid amplification
11/11/2004	CA2522154A1 Recombinant plant dicer
11/11/2004	CA2521520A1 Multiply-primed amplification of nucleic acid sequences
11/11/2004	CA2518947A1 Antiallergic composition
11/10/2004	EP1475639A2 Tumour-specific P450 protein
11/10/2004	EP1475445A1 Method of detecting micrometastasis
11/10/2004	EP1474772A2 Methods and algorithms for cell enumeration in a low-cost cytometer
11/10/2004	EP1474768A2 Methods for searching polynucleotide probe targets in databases
11/10/2004	EP1474692A2 Test strip for determining concentration of multiple analytes in a single fluid sample
11/10/2004	EP1474689A2 Method of diagnosis of inflammatory diseases using calgranulin c
11/10/2004	EP1474687A2 Marks as modifiers of the p53 pathway and methods of use
11/10/2004	EP1474685A2 Analysis of vital substances
11/10/2004	EP1474535A2 Methods and compositions for treating aids and hiv-related disorders using 1414, 1481, 1553, 34021, 1720, 1683, 1552, 1682, 1675, 12825, 9952, 5816, 10002, 1611, 1371, 14324, 126, 270, 312, 167, 326, 18926, 6747, 1793, 1784, or 2045 molecules.
11/10/2004	EP1474534A2 Genetic markers for bone mass
11/10/2004	EP1474533A2 Method of determining adenovirus particle concentration
11/10/2004	EP1474532A1 Polymerase compositions
11/10/2004	EP1474531A1 Electrophoretic assay to predict risk of cancer and the efficacy and toxicity of cancer therapy
11/10/2004	EP1474530A2 Probe correction for gene expression level detection
11/10/2004	EP1474529A2 Specific multiplex analysis of nucleic acids
11/10/2004	EP1474528A2 Methods of diagnosis of prostate cancer, compositions and methods of screening for modulators of prostate cancer
11/10/2004	EP1474527A2 Reversible oxidation of protein tyrosine phosphatases
11/10/2004	EP1474526A2 Enzyme activation protease assay
11/10/2004	EP1474524A1 Tissue engineered cartilage for drug discovery
11/10/2004	EP1474520A2 Prkag3 gene promoter and uses thereof
11/10/2004	EP1474516A2 Methods of modulating cold sensory perception
11/10/2004	EP1474515A2 Regulation of human hematopoietin receptor-like protein
11/10/2004	EP1474514A1 Deoxyribozymes
11/10/2004	EP1474513A1 Signalling aptamer complexes
11/10/2004	EP1474510A2 Compositions and methods for the detection, diagnosis and therapy of hematological malignancies
11/10/2004	EP1474504A2 Use of collections of binding sites for sample profiling and other applications
11/10/2004	EP1474449A2 Human antibodies for use as a therapeutic agent against vaccinia or small pox
11/10/2004	EP1474448A1 Rrp sequences and knockout mice and uses thereof
11/10/2004	EP1474445A1 Glycoisoforms of adiponectin and uses thereof
11/10/2004	EP1474442A2 Cytotoxic t-cell epitopes from chlamydia

1 ... 1836 1837 1838 1839 1840 1841 1842 1843 1844 1845 1846 1847 1848 1849 1850 1851 1852 1853 1854 1855 1856 ... 3003